Cargando…
Nivolumab Induced Adrenal Insufficiency: Rare Side-effect of a New Anti-cancer Therapy - Immune-checkpoint Inhibitors
Immune-checkpoint inhibitors are immuno-modulatory antibodies used in patients with advanced cancers like melanoma, renal cell carcinoma, non-small cell lung cancer, etc. They are associated with a wide array of side effects, commonly known as immune-related adverse events (irAEs), affecting dermato...
Autores principales: | Rai, Maitreyee, Go, Mylene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213652/ https://www.ncbi.nlm.nih.gov/pubmed/32399358 http://dx.doi.org/10.7759/cureus.7625 |
Ejemplares similares
-
Rare Adverse Events Related to Nivolumab, an Immune Checkpoint Inhibitor: A Case Series
por: Ganta, Nagapratap, et al.
Publicado: (2022) -
A Case of Acute Adrenal Insufficiency: A Rare but Possible Cause of Hypercalcemia
por: Aynaou, Hayat, et al.
Publicado: (2022) -
Case Report of Disseminated Adrenal Histoplasmosis and Secondary Adrenal Insufficiency
por: Jagadish, Ishitha, et al.
Publicado: (2022) -
A Rare Case of Immune-Mediated Primary Adrenal Insufficiency With Cytotoxic T-Lymphocyte Antigen-4 Inhibitor Ipilimumab in Metastatic Melanoma of Lung and Neck of Unknown Primary
por: Gaballa, Salem, et al.
Publicado: (2020) -
Vanishing Adrenal Glands: Bilateral Adrenal Hemorrhage With Adrenal Insufficiency in COVID-19 Infection
por: Majety, Priyanka, et al.
Publicado: (2023)